Clinical Research

Clinical Research

Vitti LabsTM is committed to clinical research through:

  • IND Applications
  • IRB Studies
  • University Partnerships
  • IND Applications
  • IRB Studies
  • University Partnerships

Research & Development

Vitti LabsTM research department is currently focusing on using human birth tissue bioavailable materials, mesenchymal stem cells, and extracellular vesicles to treat:

  • Pulmonary Disease Models
  • Fertility
  • Ophthalmology
  • Neurodegenerative Disease Models
  • Inflammatory Disease Models
  • Other Indications
  • Pulmonary Disease Models
  • Fertility
  • Ophthalmology
  • Neurodegenerative Disease Models
  • Inflammatory Disease Models
  • Other Indications

2024 Directives

Initial formulation
and validation		 Checking
for safety		 Checking
for efficacy		 Confirm findings in
patient population		 Therapeutic released
to market		 Monitoring
long-term safety
Therapeutic
Focus		 Vitti LabsTM
Products		 Pre-Clinical
Phase		 IRB
Approved		 IND
Submission		 Clinical Trials:
Phase I		 Clinical Trials:
Phase II		 Clinical Trials:
Phase III		 FDA Review
and Approval		 Clinical Trials:
Phase IV
Infertility (POI/PCOS) VL-OV11 Complete Approved Complete Complete In Progress
Covid VL-PX10 & VL-P22 Complete Approved Complete Complete Complete
Pulmonary Fibrosis in Long Haul Covid Patients VL-PX10 & VL-P22 Complete Approved Complete Complete In Progress/
Expanded Access
COPD VL-PX10 & VL-P22 Complete In Progress In Progress
Crohn’s Disease UCT-MSC + Biomaterials Complete In Progress In Progress
Duchenne
Muscular Dystrophy		 UCT-MSC + Biomaterials Complete In Progress In Progress
Autism UCT-MSC + Biomaterials Complete In Progress In Progress
Autism UC-Blood Biomolecules Complete In Progress In Progress
Age Related Macular
Degeneration		 MSC Exosomal Eye Serum In Progress
Glaucoma MSC Exosomal Eye Serum In Progress